| Etoricoxib Impurity 13 |
依托考昔杂质13 |
1817735-82-2 |
| Edoxaban impurity 1 |
依度沙班杂质 1 |
41374-72-5 |
| (Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime |
依地昔布EP杂质D |
1810761-43-3 |
| 17-Dehydroxy Prednisolone |
泼尼松龙EP杂质I |
13479-38-4 |
| 5-Pyrimidinecarboxamide, 2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-4-[[(4-methoxyphenyl)methyl]amino]-N-(2-pyrimidinylmethyl)- |
阿伐那非杂质 |
330784-50-4 |
| Vortioxetine Impurity 3 |
沃替西汀杂质3 |
508233-82-7 |
| 3-(4-fluorophenylaMino)-3-oxopropanoic acid |
3-(4-氟苯基氨基)-3-氧代丙酸 |
95262-10-5 |
| Beclomethasone Dipropionate Impurity |
倍氯米松二丙酸酯杂质 |
52092-12-3 |
| 5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole |
奥美沙坦酯标准品013 |
138402-33-2 |
| Etoricoxib Impurity M |
依托考昔杂质17 |
307531-95-9 |
| rac-Clopidogrel Carboxylic Acid |
氯吡格雷杂质A |
90055-55-3 |
| 6'-DesMethyl-6'-carboxy Etoricoxib |
依托考昔杂质L |
349536-39-6 |
| Valsartan Impurity 32 |
缬沙坦杂质34 |
152708-24-2 |
| Linagliptin Impurity C |
Linagliptin Impurity C |
1791405-13-4 |
| (R)-1-(2-chloroacetyl)pyrrolidine-2-carboxaMide |
R-1-氯乙酰基-2-氰基吡咯烷 |
1211679-98-9 |
| Ticagrelor Related Compound 14 |
替格瑞洛杂质14 |
2056269-94-2 |
| Vortioxetine Impurity 2 |
沃替西汀杂质2 |
1293489-69-6 |
| Irbesartan Impurity 14 |
Irbesartan Impurity 14 |
133690-91-2 |
| 4,5-dichloro-3,6-dihydroxy-phthalonitrile |
DDQ副产物 |
4640-41-9 |
| 21-Chloro-9-fluoro-11β,17-dihydroxy-16β-Methylpregn-4-ene-3,20-dione 17-Propionate |
丙酸氯倍他索杂质 |
25120-99-4 |
QQ
微信
